Evidence map›Paper›PMID 26441556›Full record

ArticleFrontiers in neuroanatomy2015

Neuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons.

Csaba Adori, Swapnali Barde, Nenad Bogdanovic, Mathias Uhlén, Rainer R Reinscheid, Gabor G Kovacs, Tomas Hökfelt

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroanatomy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. NPS neurons receive extensive input from auditory brainstem nuclei.bioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Diverse roles of pontine NPS-expressing neurons in sleep regulation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A Role for Neuropeptide S in Alcohol and Cocaine Seeking.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Csaba AdoriDepartment of Neuroscience, Karolinska Institutet Stockholm, Sweden.
Swapnali BardeDepartment of Neuroscience, Karolinska Institutet Stockholm, Sweden.
Nenad BogdanovicGeriatric Department, Institute for Clinical Medicine, Oslo University Oslo, Norway.
Mathias UhlénScience for Life Laboratory, Department of Neuroscience, Karolinska Institutet Stockholm, Sweden ; Science for Life Laboratory, Albanova University Center, Royal Institute of Technology Stockholm, Sweden.
Rainer R ReinscheidDepartment of Pharmaceutical Sciences, University of California, Irvine Irvine, CA, USA ; Department of Pharmacology, University of California, Irvine Irvine, CA, USA ; Department of Molecular Biology and Biochemistry, University of California, Irvine Irvine, CA, USA.
Gabor G KovacsInstitute of Neurology, Medical University of Vienna Vienna, Austria.
Tomas HökfeltDepartment of Neuroscience, Karolinska Institutet Stockholm, Sweden.
Karolinska Institutet · SEKTH Royal Institute of Technology · SEMedical University of Vienna · ATUniversity of California, Irvine · USUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropeptide S (NPS) is a regulatory peptide with potent pharmacological effects. In rodents, NPS is expressed in a few pontine cell clusters. Its receptor (NPSR1) is, however, widely distributed in the brain. The anxiolytic and arousal-promoting effects of NPS make the NPS-NPSR1 system an interesting potential drug target in mood-related disorders. However, so far possible disease-related mechanisms involving NPS have only been studied in rodents. To validate the relevance of these animal studies for i.a. drug development, we have explored the distribution of NPS-expressing neurons in the human pons using in situ hybridization and stereological methods and we compared the distribution of NPS mRNA expressing neurons in the human and rat brain. The calculation revealed a total number of 22,317 ± 2411 NPS mRNA-positive neurons in human, bilaterally. The majority of cells (84%) were located in the parabrachial area in human: in the extension of the medial and lateral parabrachial nuclei, in the Kölliker-Fuse nucleus and around the adjacent lateral lemniscus. In human, in sharp contrast to the rodents, only very few NPS-positive cells (5%) were found close to the locus coeruleus. In addition, we identified a smaller cell cluster (11% of all NPS cells) in the pontine central gray matter both in human and rat, which has not been described previously even in rodents. We also examined the distribution of NPSR1 mRNA-expressing neurons in the human pons. These cells were mainly located in the rostral laterodorsal tegmental nucleus, the cuneiform nucleus, the microcellular tegmental nucleus region and in the periaqueductal gray. Our results show that both NPS and NPSR1 in the human pons are preferentially localized in regions of importance for integration of visceral autonomic information and emotional behavior. The reported interspecies differences must, however, be considered when looking for targets for new pharmacotherapeutical interventions.

Indexed as

anxietyarousaldeep brain stimulation (DBS)human brainNeuropeptide S (NPS)parabrachialperiaqueductal graysudden infant death syndrome

Identifiers

PMID26441556
PMCPMC4585187
OpenAlexW2158607249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.